11/09/2015 - 15:32
The investigational infliximab biosimilar drug SB2 provided efficacy and safety equivalent to the originator drug Remicade in patients with moderate to severe rheumatoid arthritis in a phase III...
Field of Interest: Rheumatology
News Feed: Internal Medicine News - Rheumatology